论文部分内容阅读
目的:分析美托洛尔联合坎地沙坦治疗收缩性心力衰竭的临床应用效果,目的是为临床下一步治疗提供指导依据。方法:选取到该院进行收缩性心力衰竭治疗80例患者,随机进行分组,其中对照组为40例,研究组为40例。给予对照组一般常规治疗,给予研究组使用美托洛尔联合坎地沙坦治疗。结果:给予两种不同的治疗方法后,研究组的治疗总体有效率(90.00%)明显高于对照组(76.67%),研究组的射血分数以及每分搏量分数也均优于对照组,组间数据对比存在差异(P<0.05),具备统计学意义。结论:对于收缩性心力衰竭患者来说,采用美托洛尔联合坎地沙坦治疗方法,效果显著,生活质量得到提高,值得患者信赖并在临床中推广。
OBJECTIVE: To analyze the clinical effect of metoprolol combined with candesartan in the treatment of systolic heart failure, aiming to provide guidance for further clinical treatment. Methods: Totally 80 patients who were treated in the hospital for systolic heart failure were randomly divided into control group (40 cases) and study group (40 cases). The control group was given conventional treatment, and the study group was given metoprolol combined with candesartan. Results: After giving two different treatment methods, the total effective rate (90.00%) in the study group was significantly higher than that in the control group (76.67%). The ejection fraction and the per-pipetting score in the study group were also better than those in the control group There was significant difference between the two groups (P <0.05), with statistical significance. Conclusion: For patients with systolic heart failure, the combination of metoprolol and candesartan has a significant effect and an improved quality of life. It is worthy of trust and clinical promotion.